About Alan
Alan Eisenberg is a corporate affairs executive who leads teams and projects at the intersection of access and reimbursement, program strategy, public policy, and government relations. He was most recently Vice President, Global Public Policy & Government Relations at Alnylam, as Alnylam grew from a pre-commercial company to one with five launched products. At Alnylam, Eisenberg led global public policy and government relations, US public payer accounts, coverage, coding and reimbursement (including development/execution of value-based agreements), US government pricing and analysis, and patient charitable foundations.
Prior to Alnylam, Eisenberg was responsible for US Government Relations for Celgene and spent nearly a decade as Executive Vice President at the Biotechnology Innovation Organization (BIO).
Eisenberg served in a variety of senior policy making roles on Capitol Hill. He is an original author of the Average Sales Price (ASP) methodology used in Medicare Part B reimbursement and a member of teams that wrote several significant health laws, including Medicare Part D, as well as PDUFA III and pediatric exclusivity.
Eisenberg worked at Ford Motor Company in Dearborn, MI, as an economist and finance manager. Eisenberg holds master’s degrees from Harvard (Public Policy) and George Washington University (Finance), and a Bachelor of Science from Union College.